Gleevec, the targeted cancer pill that has saved more than 100,000 lives, now is saving more children with a dire leukemia. The U.S. Food and Drug Administration today approved a new use of Gleevec (imatinib) to treat children newly diagnosed with Philadelphia chromosome positive (Ph+) acute lymphoblastic ...
from bankruptcyformssite.com http://ift.tt/1fo8EQ7
via IFTTT
from bankruptcyformssite.com http://ift.tt/1fo8EQ7
via IFTTT
No comments:
Post a Comment